nodes	percent_of_prediction	percent_of_DWPC	metapath
Celecoxib—CA6—saliva—attention deficit hyperactivity disorder	0.103	0.148	CbGeAlD
Celecoxib—ORM1—saliva—attention deficit hyperactivity disorder	0.0547	0.0788	CbGeAlD
Celecoxib—PDPK1—forebrain—attention deficit hyperactivity disorder	0.0405	0.0584	CbGeAlD
Celecoxib—PDPK1—midbrain—attention deficit hyperactivity disorder	0.0267	0.0385	CbGeAlD
Celecoxib—PDPK1—nervous system—attention deficit hyperactivity disorder	0.022	0.0317	CbGeAlD
Celecoxib—MAPK14—forebrain—attention deficit hyperactivity disorder	0.0216	0.0312	CbGeAlD
Celecoxib—PDPK1—central nervous system—attention deficit hyperactivity disorder	0.0212	0.0305	CbGeAlD
Celecoxib—PDPK1—cerebellum—attention deficit hyperactivity disorder	0.0207	0.0298	CbGeAlD
Celecoxib—MAPK14—cardiovascular system—attention deficit hyperactivity disorder	0.0183	0.0264	CbGeAlD
Celecoxib—PDPK1—brain—attention deficit hyperactivity disorder	0.0168	0.0242	CbGeAlD
Celecoxib—CA12—forebrain—attention deficit hyperactivity disorder	0.0164	0.0237	CbGeAlD
Celecoxib—CA14—midbrain—attention deficit hyperactivity disorder	0.0139	0.0201	CbGeAlD
Celecoxib—CA5B—cardiovascular system—attention deficit hyperactivity disorder	0.0125	0.018	CbGeAlD
Celecoxib—MAPK14—nervous system—attention deficit hyperactivity disorder	0.0118	0.0169	CbGeAlD
Celecoxib—CA9—cerebellum—attention deficit hyperactivity disorder	0.0113	0.0164	CbGeAlD
Celecoxib—MAPK14—central nervous system—attention deficit hyperactivity disorder	0.0113	0.0163	CbGeAlD
Celecoxib—ABCC4—forebrain—attention deficit hyperactivity disorder	0.0111	0.016	CbGeAlD
Celecoxib—MAPK14—cerebellum—attention deficit hyperactivity disorder	0.0111	0.0159	CbGeAlD
Celecoxib—CA14—cerebellum—attention deficit hyperactivity disorder	0.0108	0.0155	CbGeAlD
Celecoxib—CA4—forebrain—attention deficit hyperactivity disorder	0.0102	0.0147	CbGeAlD
Celecoxib—MAPK14—brain—attention deficit hyperactivity disorder	0.00898	0.013	CbGeAlD
Celecoxib—CA12—nervous system—attention deficit hyperactivity disorder	0.00891	0.0129	CbGeAlD
Celecoxib—CA14—brain—attention deficit hyperactivity disorder	0.00874	0.0126	CbGeAlD
Celecoxib—CA4—cardiovascular system—attention deficit hyperactivity disorder	0.0086	0.0124	CbGeAlD
Celecoxib—CA12—central nervous system—attention deficit hyperactivity disorder	0.00858	0.0124	CbGeAlD
Celecoxib—CA2—forebrain—attention deficit hyperactivity disorder	0.00843	0.0122	CbGeAlD
Celecoxib—CA5B—nervous system—attention deficit hyperactivity disorder	0.008	0.0115	CbGeAlD
Celecoxib—CA5B—central nervous system—attention deficit hyperactivity disorder	0.0077	0.0111	CbGeAlD
Celecoxib—CA2—cardiovascular system—attention deficit hyperactivity disorder	0.00713	0.0103	CbGeAlD
Celecoxib—ORM1—nervous system—attention deficit hyperactivity disorder	0.00707	0.0102	CbGeAlD
Celecoxib—CA12—brain—attention deficit hyperactivity disorder	0.00681	0.00983	CbGeAlD
Celecoxib—ORM1—central nervous system—attention deficit hyperactivity disorder	0.00681	0.00982	CbGeAlD
Celecoxib—CA4—midbrain—attention deficit hyperactivity disorder	0.00671	0.00968	CbGeAlD
Celecoxib—PTGS2—forebrain—attention deficit hyperactivity disorder	0.00622	0.00898	CbGeAlD
Celecoxib—CA5B—brain—attention deficit hyperactivity disorder	0.00611	0.00881	CbGeAlD
Celecoxib—CYP2C9—cardiovascular system—attention deficit hyperactivity disorder	0.00603	0.0087	CbGeAlD
Celecoxib—ABCC4—nervous system—attention deficit hyperactivity disorder	0.006	0.00866	CbGeAlD
Celecoxib—ABCC4—central nervous system—attention deficit hyperactivity disorder	0.00578	0.00834	CbGeAlD
Celecoxib—CA2—midbrain—attention deficit hyperactivity disorder	0.00557	0.00803	CbGeAlD
Celecoxib—CA4—nervous system—attention deficit hyperactivity disorder	0.00552	0.00796	CbGeAlD
Celecoxib—CYP2D6—forebrain—attention deficit hyperactivity disorder	0.00535	0.00772	CbGeAlD
Celecoxib—CA4—central nervous system—attention deficit hyperactivity disorder	0.00531	0.00766	CbGeAlD
Celecoxib—PTGS2—cardiovascular system—attention deficit hyperactivity disorder	0.00526	0.00759	CbGeAlD
Celecoxib—CA4—cerebellum—attention deficit hyperactivity disorder	0.00519	0.00749	CbGeAlD
Celecoxib—ALB—brain—attention deficit hyperactivity disorder	0.00474	0.00684	CbGeAlD
Celecoxib—ABCC4—brain—attention deficit hyperactivity disorder	0.00459	0.00662	CbGeAlD
Celecoxib—CA2—nervous system—attention deficit hyperactivity disorder	0.00458	0.0066	CbGeAlD
Celecoxib—CA2—central nervous system—attention deficit hyperactivity disorder	0.00441	0.00635	CbGeAlD
Celecoxib—CA2—cerebellum—attention deficit hyperactivity disorder	0.00431	0.00621	CbGeAlD
Celecoxib—CA4—brain—attention deficit hyperactivity disorder	0.00422	0.00608	CbGeAlD
Celecoxib—PTGS2—midbrain—attention deficit hyperactivity disorder	0.00411	0.00593	CbGeAlD
Celecoxib—CA2—brain—attention deficit hyperactivity disorder	0.0035	0.00504	CbGeAlD
Celecoxib—PTGS2—nervous system—attention deficit hyperactivity disorder	0.00338	0.00487	CbGeAlD
Celecoxib—PTGS2—central nervous system—attention deficit hyperactivity disorder	0.00325	0.00469	CbGeAlD
Celecoxib—PTGS2—cerebellum—attention deficit hyperactivity disorder	0.00318	0.00459	CbGeAlD
Celecoxib—CYP3A4—nervous system—attention deficit hyperactivity disorder	0.00295	0.00426	CbGeAlD
Celecoxib—CYP2D6—nervous system—attention deficit hyperactivity disorder	0.00291	0.00419	CbGeAlD
Celecoxib—CYP3A4—central nervous system—attention deficit hyperactivity disorder	0.00284	0.0041	CbGeAlD
Celecoxib—CYP2D6—central nervous system—attention deficit hyperactivity disorder	0.0028	0.00403	CbGeAlD
Celecoxib—CYP2D6—cerebellum—attention deficit hyperactivity disorder	0.00273	0.00394	CbGeAlD
Celecoxib—PTGS2—brain—attention deficit hyperactivity disorder	0.00258	0.00372	CbGeAlD
Celecoxib—CYP2D6—brain—attention deficit hyperactivity disorder	0.00222	0.0032	CbGeAlD
Celecoxib—ABCC4—Platelet activation, signaling and aggregation—ADRA2A—attention deficit hyperactivity disorder	0.00117	0.0038	CbGpPWpGaD
Celecoxib—ABCC4—Hemostasis—ADRA2C—attention deficit hyperactivity disorder	0.00114	0.00373	CbGpPWpGaD
Celecoxib—CA5B—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.00113	0.00368	CbGpPWpGaD
Celecoxib—PDPK1—Signaling by GPCR—ADRA2C—attention deficit hyperactivity disorder	0.00111	0.00361	CbGpPWpGaD
Celecoxib—MAPK14—BDNF signaling pathway—BDNF—attention deficit hyperactivity disorder	0.0011	0.00358	CbGpPWpGaD
Celecoxib—MAPK14—Regulation of Androgen receptor activity—EP300—attention deficit hyperactivity disorder	0.00109	0.00356	CbGpPWpGaD
Celecoxib—PDPK1—Disease—STUB1—attention deficit hyperactivity disorder	0.00109	0.00354	CbGpPWpGaD
Celecoxib—MAPK14—Innate Immune System—MB21D1—attention deficit hyperactivity disorder	0.00108	0.00353	CbGpPWpGaD
Celecoxib—PDPK1—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	0.00108	0.00353	CbGpPWpGaD
Celecoxib—MAPK14—IL-4 Signaling Pathway—EP300—attention deficit hyperactivity disorder	0.00108	0.00351	CbGpPWpGaD
Celecoxib—MAPK14—Role of Calcineurin-dependent NFAT signaling in lymphocytes—EP300—attention deficit hyperactivity disorder	0.00108	0.00351	CbGpPWpGaD
Celecoxib—CA12—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.00104	0.00341	CbGpPWpGaD
Celecoxib—MAPK14—Platelet activation, signaling and aggregation—ADRA2A—attention deficit hyperactivity disorder	0.00102	0.00333	CbGpPWpGaD
Celecoxib—PDPK1—Hemostasis—ADRA2A—attention deficit hyperactivity disorder	0.00101	0.0033	CbGpPWpGaD
Celecoxib—ALB—Platelet activation, signaling and aggregation—ADRA2C—attention deficit hyperactivity disorder	0.001	0.00328	CbGpPWpGaD
Celecoxib—MAPK14—ATF-2 transcription factor network—EP300—attention deficit hyperactivity disorder	0.001	0.00327	CbGpPWpGaD
Celecoxib—MAPK14—Kit receptor signaling pathway—EP300—attention deficit hyperactivity disorder	0.001	0.00327	CbGpPWpGaD
Celecoxib—MAPK14—p53 pathway—EP300—attention deficit hyperactivity disorder	0.001	0.00327	CbGpPWpGaD
Celecoxib—MAPK14—Hemostasis—ADRA2C—attention deficit hyperactivity disorder	0.001	0.00327	CbGpPWpGaD
Celecoxib—MAPK14—Developmental Biology—ANK3—attention deficit hyperactivity disorder	0.001	0.00326	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	0.000974	0.00318	CbGpPWpGaD
Celecoxib—MAPK14—MAPK Signaling Pathway—BDNF—attention deficit hyperactivity disorder	0.000969	0.00316	CbGpPWpGaD
Celecoxib—MAPK14—Regulation of retinoblastoma protein—EP300—attention deficit hyperactivity disorder	0.000916	0.00299	CbGpPWpGaD
Celecoxib—PDPK1—Immune System—POLR3A—attention deficit hyperactivity disorder	0.000891	0.00291	CbGpPWpGaD
Celecoxib—MAPK14—Integrated Pancreatic Cancer Pathway—BDNF—attention deficit hyperactivity disorder	0.000874	0.00285	CbGpPWpGaD
Celecoxib—CA14—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000855	0.00279	CbGpPWpGaD
Celecoxib—CA14—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000855	0.00279	CbGpPWpGaD
Celecoxib—CA14—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000841	0.00274	CbGpPWpGaD
Celecoxib—CA5A—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000833	0.00272	CbGpPWpGaD
Celecoxib—CA6—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000833	0.00272	CbGpPWpGaD
Celecoxib—CA5A—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000833	0.00272	CbGpPWpGaD
Celecoxib—CA6—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000833	0.00272	CbGpPWpGaD
Celecoxib—CA4—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000832	0.00272	CbGpPWpGaD
Celecoxib—PDPK1—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	0.000827	0.0027	CbGpPWpGaD
Celecoxib—PTGS2—Spinal Cord Injury—BDNF—attention deficit hyperactivity disorder	0.000821	0.00268	CbGpPWpGaD
Celecoxib—CA5A—Metabolism—DPYD—attention deficit hyperactivity disorder	0.00082	0.00267	CbGpPWpGaD
Celecoxib—CA6—Metabolism—DPYD—attention deficit hyperactivity disorder	0.00082	0.00267	CbGpPWpGaD
Celecoxib—CA2—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000798	0.0026	CbGpPWpGaD
Celecoxib—MAPK14—Innate Immune System—POLR3A—attention deficit hyperactivity disorder	0.000795	0.00259	CbGpPWpGaD
Celecoxib—MAPK14—p73 transcription factor network—EP300—attention deficit hyperactivity disorder	0.000793	0.00259	CbGpPWpGaD
Celecoxib—CYP2D6—Phase 1 - Functionalization of compounds—MAOA—attention deficit hyperactivity disorder	0.000792	0.00258	CbGpPWpGaD
Celecoxib—CYP2C9—Phase 1 - Functionalization of compounds—MAOA—attention deficit hyperactivity disorder	0.000785	0.00256	CbGpPWpGaD
Celecoxib—CA14—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000782	0.00255	CbGpPWpGaD
Celecoxib—PTGS2—Aryl Hydrocarbon Receptor—EP300—attention deficit hyperactivity disorder	0.000781	0.00255	CbGpPWpGaD
Celecoxib—CA5B—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000778	0.00254	CbGpPWpGaD
Celecoxib—CA5B—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000778	0.00254	CbGpPWpGaD
Celecoxib—MAPK14—Glucocorticoid receptor regulatory network—EP300—attention deficit hyperactivity disorder	0.00077	0.00251	CbGpPWpGaD
Celecoxib—CA5B—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000765	0.0025	CbGpPWpGaD
Celecoxib—CA5A—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000762	0.00249	CbGpPWpGaD
Celecoxib—CA6—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000762	0.00249	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	0.00076	0.00248	CbGpPWpGaD
Celecoxib—PDPK1—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	0.000751	0.00245	CbGpPWpGaD
Celecoxib—PDPK1—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	0.000723	0.00236	CbGpPWpGaD
Celecoxib—CA12—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000721	0.00235	CbGpPWpGaD
Celecoxib—CA12—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000721	0.00235	CbGpPWpGaD
Celecoxib—CA5B—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000711	0.00232	CbGpPWpGaD
Celecoxib—CA12—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000709	0.00231	CbGpPWpGaD
Celecoxib—MAPK14—Developmental Biology—CACNB2—attention deficit hyperactivity disorder	0.000704	0.0023	CbGpPWpGaD
Celecoxib—CA14—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000683	0.00223	CbGpPWpGaD
Celecoxib—CA9—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000673	0.00219	CbGpPWpGaD
Celecoxib—PDPK1—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	0.000672	0.00219	CbGpPWpGaD
Celecoxib—CA5A—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000666	0.00217	CbGpPWpGaD
Celecoxib—CA6—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000666	0.00217	CbGpPWpGaD
Celecoxib—CA12—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000659	0.00215	CbGpPWpGaD
Celecoxib—PDPK1—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	0.000656	0.00214	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	0.000653	0.00213	CbGpPWpGaD
Celecoxib—PDPK1—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	0.000651	0.00212	CbGpPWpGaD
Celecoxib—CA14—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000651	0.00212	CbGpPWpGaD
Celecoxib—MAPK14—Developmental Biology—CACNA1C—attention deficit hyperactivity disorder	0.000644	0.0021	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	0.00064	0.00209	CbGpPWpGaD
Celecoxib—PDPK1—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	0.00064	0.00209	CbGpPWpGaD
Celecoxib—CA6—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000634	0.00207	CbGpPWpGaD
Celecoxib—CA5A—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000634	0.00207	CbGpPWpGaD
Celecoxib—ALB—Transmembrane transport of small molecules—SLC9A9—attention deficit hyperactivity disorder	0.000633	0.00207	CbGpPWpGaD
Celecoxib—PDPK1—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	0.000632	0.00206	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—MB21D1—attention deficit hyperactivity disorder	0.000631	0.00206	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	0.000627	0.00205	CbGpPWpGaD
Celecoxib—CA5B—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000622	0.00203	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—STUB1—attention deficit hyperactivity disorder	0.000611	0.00199	CbGpPWpGaD
Celecoxib—PDPK1—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	0.00061	0.00199	CbGpPWpGaD
Celecoxib—ALB—Transmembrane transport of small molecules—GABRQ—attention deficit hyperactivity disorder	0.000604	0.00197	CbGpPWpGaD
Celecoxib—ABCC4—Hemostasis—ADRA2A—attention deficit hyperactivity disorder	0.000601	0.00196	CbGpPWpGaD
Celecoxib—CA5B—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000592	0.00193	CbGpPWpGaD
Celecoxib—PDPK1—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	0.000591	0.00193	CbGpPWpGaD
Celecoxib—PDPK1—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	0.000588	0.00192	CbGpPWpGaD
Celecoxib—PDPK1—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	0.000581	0.00189	CbGpPWpGaD
Celecoxib—CA12—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000576	0.00188	CbGpPWpGaD
Celecoxib—CA4—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000575	0.00187	CbGpPWpGaD
Celecoxib—CA4—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000575	0.00187	CbGpPWpGaD
Celecoxib—PDPK1—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	0.000574	0.00187	CbGpPWpGaD
Celecoxib—CA4—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000565	0.00184	CbGpPWpGaD
Celecoxib—PTGS2—Integrated Pancreatic Cancer Pathway—BDNF—attention deficit hyperactivity disorder	0.000559	0.00182	CbGpPWpGaD
Celecoxib—CA2—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000551	0.0018	CbGpPWpGaD
Celecoxib—CA2—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000551	0.0018	CbGpPWpGaD
Celecoxib—CA12—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000548	0.00179	CbGpPWpGaD
Celecoxib—CA2—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000542	0.00177	CbGpPWpGaD
Celecoxib—PDPK1—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	0.000534	0.00174	CbGpPWpGaD
Celecoxib—ALB—Platelet activation, signaling and aggregation—ADRA2A—attention deficit hyperactivity disorder	0.000527	0.00172	CbGpPWpGaD
Celecoxib—MAPK14—TGF-beta Signaling Pathway—EP300—attention deficit hyperactivity disorder	0.000526	0.00172	CbGpPWpGaD
Celecoxib—MAPK14—Hemostasis—ADRA2A—attention deficit hyperactivity disorder	0.000526	0.00172	CbGpPWpGaD
Celecoxib—CA4—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000526	0.00171	CbGpPWpGaD
Celecoxib—CA14—Metabolism—COMT—attention deficit hyperactivity disorder	0.000518	0.00169	CbGpPWpGaD
Celecoxib—CYP3A4—Phase 1 - Functionalization of compounds—MAOA—attention deficit hyperactivity disorder	0.000518	0.00169	CbGpPWpGaD
Celecoxib—ALB—Hemostasis—ADRA2C—attention deficit hyperactivity disorder	0.000517	0.00169	CbGpPWpGaD
Celecoxib—PDPK1—Disease—SNAP25—attention deficit hyperactivity disorder	0.000515	0.00168	CbGpPWpGaD
Celecoxib—CA14—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000514	0.00168	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	0.000506	0.00165	CbGpPWpGaD
Celecoxib—CA5A—Metabolism—COMT—attention deficit hyperactivity disorder	0.000505	0.00165	CbGpPWpGaD
Celecoxib—CA6—Metabolism—COMT—attention deficit hyperactivity disorder	0.000505	0.00165	CbGpPWpGaD
Celecoxib—CA2—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000504	0.00164	CbGpPWpGaD
Celecoxib—CA5A—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000501	0.00164	CbGpPWpGaD
Celecoxib—CA6—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000501	0.00164	CbGpPWpGaD
Celecoxib—CA9—Cellular responses to stress—EP300—attention deficit hyperactivity disorder	0.000501	0.00163	CbGpPWpGaD
Celecoxib—ABCC4—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	0.000487	0.00159	CbGpPWpGaD
Celecoxib—PTGS2—C-MYB transcription factor network—EP300—attention deficit hyperactivity disorder	0.000482	0.00157	CbGpPWpGaD
Celecoxib—CA5B—Metabolism—COMT—attention deficit hyperactivity disorder	0.000471	0.00154	CbGpPWpGaD
Celecoxib—CA5B—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000468	0.00153	CbGpPWpGaD
Celecoxib—CA9—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000464	0.00151	CbGpPWpGaD
Celecoxib—CA9—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000464	0.00151	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—POLR3A—attention deficit hyperactivity disorder	0.000463	0.00151	CbGpPWpGaD
Celecoxib—MAPK14—Gene Expression—POLR3A—attention deficit hyperactivity disorder	0.00046	0.0015	CbGpPWpGaD
Celecoxib—CA4—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000459	0.0015	CbGpPWpGaD
Celecoxib—CA9—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000457	0.00149	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	0.000443	0.00145	CbGpPWpGaD
Celecoxib—CA2—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.00044	0.00144	CbGpPWpGaD
Celecoxib—CA4—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000437	0.00143	CbGpPWpGaD
Celecoxib—CA12—Metabolism—COMT—attention deficit hyperactivity disorder	0.000437	0.00142	CbGpPWpGaD
Celecoxib—ALB—SLC-mediated transmembrane transport—SLC6A3—attention deficit hyperactivity disorder	0.000433	0.00141	CbGpPWpGaD
Celecoxib—CA12—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000433	0.00141	CbGpPWpGaD
Celecoxib—CA9—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000425	0.00139	CbGpPWpGaD
Celecoxib—CYP2D6—Biological oxidations—COMT—attention deficit hyperactivity disorder	0.000424	0.00138	CbGpPWpGaD
Celecoxib—CYP2D6—Biological oxidations—MAOA—attention deficit hyperactivity disorder	0.000421	0.00137	CbGpPWpGaD
Celecoxib—CYP2C9—Biological oxidations—COMT—attention deficit hyperactivity disorder	0.00042	0.00137	CbGpPWpGaD
Celecoxib—CA2—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000419	0.00137	CbGpPWpGaD
Celecoxib—CYP2D6—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	0.000418	0.00136	CbGpPWpGaD
Celecoxib—CYP2C9—Biological oxidations—MAOA—attention deficit hyperactivity disorder	0.000417	0.00136	CbGpPWpGaD
Celecoxib—CYP2C9—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	0.000414	0.00135	CbGpPWpGaD
Celecoxib—PDPK1—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	0.000412	0.00134	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	0.000395	0.00129	CbGpPWpGaD
Celecoxib—MAPK14—Integrated Pancreatic Cancer Pathway—EP300—attention deficit hyperactivity disorder	0.000391	0.00128	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	0.000388	0.00126	CbGpPWpGaD
Celecoxib—PDPK1—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	0.000374	0.00122	CbGpPWpGaD
Celecoxib—CA9—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000371	0.00121	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	0.00036	0.00118	CbGpPWpGaD
Celecoxib—PTGS2—Disease—STUB1—attention deficit hyperactivity disorder	0.00036	0.00118	CbGpPWpGaD
Celecoxib—CA9—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000353	0.00115	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	0.000349	0.00114	CbGpPWpGaD
Celecoxib—CA4—Metabolism—COMT—attention deficit hyperactivity disorder	0.000348	0.00114	CbGpPWpGaD
Celecoxib—CA4—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000346	0.00113	CbGpPWpGaD
Celecoxib—PDPK1—Hemostasis—EP300—attention deficit hyperactivity disorder	0.000345	0.00113	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	0.000343	0.00112	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	0.000339	0.00111	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	0.000339	0.00111	CbGpPWpGaD
Celecoxib—CA2—Metabolism—COMT—attention deficit hyperactivity disorder	0.000334	0.00109	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	0.000332	0.00108	CbGpPWpGaD
Celecoxib—CA2—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000331	0.00108	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	0.000326	0.00106	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	0.000316	0.00103	CbGpPWpGaD
Celecoxib—PDPK1—Innate Immune System—EP300—attention deficit hyperactivity disorder	0.000311	0.00101	CbGpPWpGaD
Celecoxib—MAPK14—Cellular responses to stress—EP300—attention deficit hyperactivity disorder	0.000302	0.000986	CbGpPWpGaD
Celecoxib—CA9—Metabolism—COMT—attention deficit hyperactivity disorder	0.000281	0.000918	CbGpPWpGaD
Celecoxib—CA9—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000279	0.000911	CbGpPWpGaD
Celecoxib—CYP3A4—Biological oxidations—COMT—attention deficit hyperactivity disorder	0.000277	0.000904	CbGpPWpGaD
Celecoxib—CYP3A4—Biological oxidations—MAOA—attention deficit hyperactivity disorder	0.000275	0.000897	CbGpPWpGaD
Celecoxib—CYP3A4—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	0.000273	0.000891	CbGpPWpGaD
Celecoxib—ALB—Hemostasis—ADRA2A—attention deficit hyperactivity disorder	0.000272	0.000887	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000259	0.000846	CbGpPWpGaD
Celecoxib—PTGS2—Integrated Pancreatic Cancer Pathway—EP300—attention deficit hyperactivity disorder	0.00025	0.000816	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	0.00023	0.000752	CbGpPWpGaD
Celecoxib—CA14—Metabolism—EP300—attention deficit hyperactivity disorder	0.000222	0.000725	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	0.000221	0.000721	CbGpPWpGaD
Celecoxib—ALB—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	0.00022	0.000719	CbGpPWpGaD
Celecoxib—CA6—Metabolism—EP300—attention deficit hyperactivity disorder	0.000216	0.000706	CbGpPWpGaD
Celecoxib—CA5A—Metabolism—EP300—attention deficit hyperactivity disorder	0.000216	0.000706	CbGpPWpGaD
Celecoxib—ALB—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.00021	0.000684	CbGpPWpGaD
Celecoxib—ABCC4—Hemostasis—EP300—attention deficit hyperactivity disorder	0.000205	0.000669	CbGpPWpGaD
Celecoxib—CA5B—Metabolism—EP300—attention deficit hyperactivity disorder	0.000202	0.000659	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	0.000201	0.000657	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	0.000187	0.000611	CbGpPWpGaD
Celecoxib—CA12—Metabolism—EP300—attention deficit hyperactivity disorder	0.000187	0.000611	CbGpPWpGaD
Celecoxib—MAPK14—Developmental Biology—EP300—attention deficit hyperactivity disorder	0.000183	0.000597	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	0.000181	0.000592	CbGpPWpGaD
Celecoxib—PDPK1—Immune System—EP300—attention deficit hyperactivity disorder	0.000181	0.000591	CbGpPWpGaD
Celecoxib—MAPK14—Hemostasis—EP300—attention deficit hyperactivity disorder	0.00018	0.000586	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000179	0.000584	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000179	0.000584	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	0.000178	0.000582	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000176	0.000575	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	0.000176	0.000575	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000173	0.000565	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000172	0.00056	CbGpPWpGaD
Celecoxib—PTGS2—Disease—SNAP25—attention deficit hyperactivity disorder	0.000171	0.000557	CbGpPWpGaD
Celecoxib—PDPK1—Disease—EP300—attention deficit hyperactivity disorder	0.000167	0.000546	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	0.000164	0.000535	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000164	0.000534	CbGpPWpGaD
Celecoxib—MAPK14—Innate Immune System—EP300—attention deficit hyperactivity disorder	0.000162	0.000527	CbGpPWpGaD
Celecoxib—CA4—Metabolism—EP300—attention deficit hyperactivity disorder	0.000149	0.000487	CbGpPWpGaD
Celecoxib—ALB—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000145	0.000472	CbGpPWpGaD
Celecoxib—ALB—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000145	0.000472	CbGpPWpGaD
Celecoxib—CA2—Metabolism—EP300—attention deficit hyperactivity disorder	0.000143	0.000467	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000143	0.000467	CbGpPWpGaD
Celecoxib—ALB—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000142	0.000465	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000136	0.000444	CbGpPWpGaD
Celecoxib—ALB—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000132	0.000432	CbGpPWpGaD
Celecoxib—CA9—Metabolism—EP300—attention deficit hyperactivity disorder	0.000121	0.000394	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—TPH2—attention deficit hyperactivity disorder	0.00012	0.00039	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.00012	0.00039	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000119	0.000387	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000119	0.000387	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000118	0.000384	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—EP300—attention deficit hyperactivity disorder	0.000117	0.000382	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000117	0.00038	CbGpPWpGaD
Celecoxib—ALB—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000116	0.000378	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	0.000115	0.000375	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000113	0.000369	CbGpPWpGaD
Celecoxib—ALB—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.00011	0.00036	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000109	0.000357	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—COMT—attention deficit hyperactivity disorder	0.000108	0.000354	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000108	0.000354	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000108	0.000351	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism of lipids and lipoproteins—EP300—attention deficit hyperactivity disorder	0.000104	0.000341	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—SNAP25—attention deficit hyperactivity disorder	9.56e-05	0.000312	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—SNAP25—attention deficit hyperactivity disorder	9.48e-05	0.000309	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—EP300—attention deficit hyperactivity disorder	9.41e-05	0.000307	CbGpPWpGaD
Celecoxib—ALB—Hemostasis—EP300—attention deficit hyperactivity disorder	9.28e-05	0.000303	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—ADRA2A—attention deficit hyperactivity disorder	9.1e-05	0.000297	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—ADRA2A—attention deficit hyperactivity disorder	9.02e-05	0.000294	CbGpPWpGaD
Celecoxib—ALB—Metabolism—COMT—attention deficit hyperactivity disorder	8.77e-05	0.000286	CbGpPWpGaD
Celecoxib—ALB—Metabolism—MAOA—attention deficit hyperactivity disorder	8.71e-05	0.000284	CbGpPWpGaD
Celecoxib—ALB—Metabolism of lipids and lipoproteins—EP300—attention deficit hyperactivity disorder	8.45e-05	0.000276	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—CACNB2—attention deficit hyperactivity disorder	7.82e-05	0.000255	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—TPH2—attention deficit hyperactivity disorder	7.82e-05	0.000255	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—DPYD—attention deficit hyperactivity disorder	7.69e-05	0.000251	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—COMT—attention deficit hyperactivity disorder	7.24e-05	0.000236	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—MAOA—attention deficit hyperactivity disorder	7.19e-05	0.000235	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—COMT—attention deficit hyperactivity disorder	7.18e-05	0.000234	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—CACNA1C—attention deficit hyperactivity disorder	7.15e-05	0.000233	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—MAOA—attention deficit hyperactivity disorder	7.13e-05	0.000233	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism of lipids and lipoproteins—EP300—attention deficit hyperactivity disorder	6.91e-05	0.000226	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—SNAP25—attention deficit hyperactivity disorder	6.25e-05	0.000204	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—EP300—attention deficit hyperactivity disorder	6.09e-05	0.000199	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—ADRA2A—attention deficit hyperactivity disorder	5.95e-05	0.000194	CbGpPWpGaD
Celecoxib—PTGS2—Disease—EP300—attention deficit hyperactivity disorder	5.55e-05	0.000181	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—COMT—attention deficit hyperactivity disorder	4.74e-05	0.000155	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—MAOA—attention deficit hyperactivity disorder	4.7e-05	0.000153	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—EP300—attention deficit hyperactivity disorder	4.65e-05	0.000152	CbGpPWpGaD
Celecoxib—ALB—Metabolism—EP300—attention deficit hyperactivity disorder	3.76e-05	0.000123	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—EP300—attention deficit hyperactivity disorder	3.11e-05	0.000101	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—EP300—attention deficit hyperactivity disorder	3.08e-05	0.0001	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—EP300—attention deficit hyperactivity disorder	2.03e-05	6.63e-05	CbGpPWpGaD
